A Study to Test MK-0941 in Adults With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0941-018)

• Status: Completed
• Trial end date: 2010-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to test the effect MK-0941 as add-on therapy for adults taking insulin for Type 2 Diabetes.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Insulin; Insulin, Globin Zinc

Criteria

Inclusion Criteria:

• Participant has Type 2 Diabetes Mellitus

Exclusion Criteria:

• Participant has a history of Type 1 Diabetes Mellitus or ketoacidosis

• Participant is on a weight loss program and is not in the maintenance phase or is taking a weight loss medication

• Participant has had surgery within 30 days of starting the study or has planned major surgery